Sands Capital, an investment management company, released its “Sands Capital Select Growth Fund” Q4 2024 investor letter. A ...
DexCom's recent licensing deal with Nanowear is likely to reinforce the broader potential of CGMs in continuous metabolic ...
DexCom DXCM recently signed a licensing and data partnership with a privately held healthcare-at-home digital diagnostics company — Nanowear. Per the terms of the agreement, Nanowear will use ...
DexCom Inc. closed 52.01% short of its 52-week high of $141.99, which the company achieved on April 9th.
Pioneering the shift from bulky, short-term heart monitors to sleek, wire-free patches, iRhythm Technologies (NASDAQ:IRTC) provides wearable cardiac monitoring devices and AI-powered analysis services ...
Zacks.com on MSN7d
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 ApprovalDexCom receives a warning letter from the FDA citing several issues with its popular G6 & G7 sensor manufacturing. The ...
The general mood among these heavyweight investors is divided, with 12% leaning bullish and 50% bearish. Among these notable ...
(Reuters) -Megacap U.S. tech companies including Apple (NASDAQ: AAPL) and retail giants Walmart (NYSE: WMT) and Nike (NYSE: ...
We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to take a look at where DexCom, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback